ASHP Midyear 2015: Direct Medical Costs from Post-Marketing Adverse Drug Reactions: Focus on GLP-1, DPP-4 & SGLT2 Type 2 Diabetes Medications

Hoffman, K.B., Giron, A., & Dimbil, M. (2015, December). Direct Medical Costs from Post-Marketing Adverse Drug Reactions: Focus on GLP-1, DPP-4, & SGLT2 Type 2 Diabetes Medications. Poster presented at ASHP Midyear Clinal Meeting and Exhibition, New Orleans, LA.

DOWNLOAD NOW:

Evidex Signal Management

A next generation pharmacovigilance workflow platform that allows an organization to track and resolve safety signals and inquiries.

face.png

Best-in-Class UX/UI

Built within the Evidex framework, Evidex Signal Management provides audit ready tools that safety reviewers want to use

gears.png

Automation Made Easy

Fully integrated and automated signal detection from multiple data sources, powered by Evidex Data & Analytics provides a wholistic, modern approach to pharmacovigilance

paper.png

Validated Off-the-Shelf

Validated off-the-shelf configuration based on GVP Module IX offers fast, compliant, and lean implementation, while maintaining the flexibility to meet any organization's unique needs

See Pharmacovigilance 2.0 for yourself.

Request a Demonstration Now!

SIGN UP FOR FREE TRIAL